China’s growing biotechnology sector is facing increased scrutiny from US [...]
Phase 3 data presented at ASCO 2026 suggest a PSMA-targeted [...]
China’s growing biotechnology sector is facing increased scrutiny from US [...]
Phase 3 data presented at ASCO 2026 suggest a PSMA-targeted [...]